Clinical trial Recruiting at 1 site Interventional Ages 5 to 12

Ultrasound therapy for children with speech sound disorders

Official title: Communication in Children With or Without Biomedical Conditions: Speech and Language Profile, Related Outcomes and Articulation Treatment With Ultrasound

Run by The University of Hong Kong · NCT06831396 · Data updated 2026-11-12

This study is testing if using ultrasound to help kids with speech sound disorders, especially those with brain tumors or cleft palates, can improve their speech by showing them how to move their tongues correctly.

More Speech Sound Disorder trials

Quick facts

Study typeInterventional
Ages5 Years to 12 Years
SexAll
Enrollment60 (estimated)
SponsorThe University of Hong Kong
Academic / other
Locations1 site (Hong Kong)
StatusRecruiting
StartedNovember 11, 2023
Main results expectedAugust 30, 2026
Study endsOctober 30, 2026
Registry record updatedMarch 10, 2026
Trial IDNCT06831396 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children with brain tumors or cleft palates who have articulation errors and speak Cantonese.

Probably not a fit

Patients with syndromes, significant language disorders, or other biomedical conditions like cerebral palsy or autism may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of ultrasound-aided articulation therapy for children with speech sound disorders, specifically targeting those with brain tumors or cleft palates. Participants will be randomly assigned to either a high or low treatment intensity group, with the aim of assessing how ultrasound visualization of tongue movements can aid in correcting articulation errors. The study will include children who speak Cantonese and will control for variables such as age and gender. A waitlist control group will also be included for comparison.

Why it matters

Potential benefit: If successful, this therapy could significantly improve speech articulation in children with specific speech sound disorders.

How similar studies have gone: While the use of ultrasound in speech therapy is a novel approach, similar studies have shown promise in improving articulation in children.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Primary diagnosis of speech sound disorder with errors on lingual target sounds
* Probe accuracy \<70% on the primary target sound at baseline
* Cantonese as the first language
* Hearing thresholds ≤25 dB in at least one ear, with no hearing loss exceeding 50 dB in the other ear
* No syndromes or obvious dysmorphic features
* No language disorders associated with biomedical conditions (e.g., cerebral palsy, autism spectrum disorder)
* No oronasal fistula identified on oral examination or diagnosed velopharyngeal insufficiency

Exclusion Criteria:

* Presence of syndromes or dysmorphic features
* Language disorder associated with biomedical conditions (e.g., cerebral palsy, autism spectrum disorder)
* Hearing thresholds \>25 dB in one ear and \>50 dB in the other ear Planned surgical intervention during the study period

Where it's running

  • Hong Kong Children's Hospital and Child Assessment Centre of The Duchess of Kent Children's Hospital
    Hong Kong, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.